Annual report pursuant to Section 13 and 15(d)

Quarterly Financial Data - Unaudited (Tables)

v3.8.0.1
Quarterly Financial Data - Unaudited (Tables)
12 Months Ended
Sep. 30, 2017
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Quarterly Financial Data - Unaudited
 
Fiscal 2017
 
 
 
1st Quarter
 
2nd Quarter
 
3rd Quarter
 
4th Quarter
 
 
 
(in thousands, except per share amounts)
 
 
Net sales
$
419,498

 
$
569,924

 
$
574,592

 
$
490,464

 
  
Gross profit
120,678

 
183,529

 
183,273

 
145,328

 
  
Net income attributable to Central Garden & Pet Company
7,637

(1
)
34,684

 
32,248

 
4,259

 
 
Net income per share:
 
 
 
 
 
 
 
 
 
Basic
$
0.15

 
$
0.69

 
$
0.64

 
$
0.08

 
 
Diluted
$
0.15

 
$
0.67

 
$
0.62

 
$
0.08

 
 
Weighted average common shares outstanding:
 
 
 
 
 
 
 
 
 
Basic
49,665

 
50,079

 
50,507

 
50,654

 
  
Diluted
51,810

 
51,983

 
51,825

 
51,935

 
  
(1) The Company recognized a $2.0 million gain in its Garden segment from the sale of a distribution facility during the first quarter of fiscal 2017.
 
Fiscal 2016
 
 
 
1st Quarter
 
2nd Quarter
 
3rd Quarter
 
4th Quarter
 
 
 
(in thousands, except per share amounts)
 
 
Net sales
$
359,812

 
$
541,249

 
$
514,544

 
$
413,412

 
  
Gross profit
99,786

 
169,339

 
163,745

 
120,180

 
  
Net income (loss) attributable to Central Garden & Pet Company
(8,602
)
(1
)
32,697

 
26,030

(2
)
(5,611
)
 
(3)
Net income (loss) per share:
 
 
 
 
 
 
 
 
 
Basic
$
(0.18
)
 
$
0.67

 
$
0.53

 
$
(0.11
)
 
 
Diluted
$
(0.18
)
 
$
0.65

 
$
0.51

 
$
(0.11
)
 
 
Weighted average common shares outstanding:
 
 
 
 
 
 
 
 
 
Basic
48,566

 
48,717

 
49,120

 
49,453

 
  
Diluted
48,566

 
50,445

 
51,063

 
49,453

 
  

(1)
During the first quarter of fiscal 2016, the Company redeemed its 2018 Notes and issued senior notes due November 2023. As a result of the bond redemption, the Company incurred incremental expenses of $14.3 million, comprised of a call premium payment of $8.3 million, a $2.7 million payment of overlapping interest expense for 30 days and a $3.3 million non-cash charge for the write off of unamortized deferred financing costs and discount related to the 2018 Notes.
(2)
The Company recognized a $2.4 million gain in its Pet segment from the sale of a manufacturing plant resulting from rationalizing its facilities to reduce excess capacity during the third quarter of fiscal 2016.
(3)
The Company recognized a non-cash impairment charge of $16.6 million related to its investment in two joint ventures as a result of changes in marketplace conditions, and a non-cash impairment charge in its Pet segment of $1.8 million related to the impairment of certain indefinite-lived intangible assets due to declining sales volume during the fourth quarter of fiscal 2016.